A Kaiser Permanante study surveyed bladder cancer patients and found that current and former smokers were aware of a connection between smoking and their disease.
More than half of bladder cancers in the U.S. are the result of smoking, and 90% of smokers with the disease are aware of the connection, according to a new study.
" is actually the second most common smoking-related cancer, second only to lung," said lead author Dr. Jeffrey C. Bassett of Kaiser Permanente Southern California in Anaheim.
Although previous studies had suggested that few people understood the connection between bladder cancer and tobacco, this new study found the opposite, he said.
"Bladder cancer patients smoking at diagnosis appear to accept that their own smoking caused their cancer, positioning them for a more motivated (and more likely successful) attempt at quitting," Bassett said.
He and his team surveyed 1,198 men and women who had been diagnosed with bladder cancer between 2006 and 2009 in the California Cancer Registry about their smoking history, and 790 completed the survey.
Read the complete article on Medscape: http://bit.ly/1tNny6u
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen